Long-term cocaine use and antiretroviral therapy are associated with silent coronary artery disease in African Americans with HIV infection who have no cardiovascular symptoms

Clinical Infectious Diseases

Volumn 46, Issue 4, 2008, Pages 600-610

  Lai, Shenghan ^a   Fishman, Elliot K ^a   Lai, Hong ^a   Moore, Richard ^a   Cofrancesco Jr , Joseph ^a   Pannu, Harpreet ^a   Tong, Wenjing ^a   Du, Jiefu ^a,b   Bartlett, John ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ATAZANAVIR; COCAINE; DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; ZIDOVUDINE;

ADULT; AFRICAN AMERICAN; ARTICLE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONFIDENCE INTERVAL; CONTRAST ENHANCEMENT; CORONARY ARTERY OBSTRUCTION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; SUBSTANCE ABUSE; UNITED STATES; COCAINE-RELATED DISORDERS; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; ETHNOLOGY; HIV INFECTIONS; MIDDLE AGED; STATISTICS AND NUMERICAL DATA;

ADULT; AFRICAN AMERICANS; ANTI-RETROVIRAL AGENTS; BALTIMORE; COCAINE-RELATED DISORDERS; COHORT STUDIES; CORONARY ARTERY DISEASE; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 39349094372     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/526782     Document Type: Article

References (35)

1. Carr A, Cooper DA. Adverse effects of antiretroviral therapy. Lancet 2000; 356:1423-30.
2. Walli R, Herfort O, Michl GM, et al. Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients. AIDS 1998; 12:F167-73.
3. Vergis EN, Paterson DL, Wagener MM, Swindells S, Singh N. Dyslipidaemia in HIV-infected patients: association with adherence to potent antiretroviral therapy. Int J STD AIDS 2001; 12:463-8.
4. Galli M, Ridolfo AL, Adorni F, et al. Body habitus changes and metabolic alterations in protease inhibitor-naive HIV-1-infected patients treated with two nucleoside reverse transcriptase inhibitors. J Acquir Immune Defic Syndr 2002; 29:21-31.
5. Friis-Møller N, Weber R, Reiss P, et al. Cardiovascular risk factors in HIV patients - association with antiretroviral therapy: results from the DAD study. AIDS 2003; 17:1179-93.
6. Carr A, Samaras K, Thorisdottir A, Kaufmann GR, Chisholm DJ, Cooper DA. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet 1999; 353:2093-9.
7. The Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 2003; 349:1993-2004.
8. Bozzette SA, Ake CF, Tam HK, Chang SW, Louis TA. Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. N Engl J Med 2003; 348:702-10.
9. Lucas GM, Cheever LW, Chaisson RE, Moore RD. Detrimental effects of continued illicit drug use on the treatment of HIV infection. J Acquir Immune Defic Syndr 2001; 27:251-9.
10. Haubrich RH, Little S, Currier JS, Forthal DN, Kemper C. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. AIDS 1999; 13:1099-107.
11. Gifford AL, Bormann JE, Shively MJ, Wright BC, Richman DD, Bozzette SA. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. J Acquir Immune Defic Syndr 2000; 23:386-95.
12. Arnsten JH, Demas PA, Grant RW, et al. Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J Gen Intern Med 2002; 17:377-81.
13. Austen WG, Edwards JE, Frye RL, et al. A reporting system on patients evaluated for coronary artert disease: report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council of Cardiovascular Surgery, American Heart Association. Circulation 1975; 51:5-40.
14. Clopper C, Pearson S. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika 1934; 26:404-13.
15. Hirji KF, Mehta CR, Patel NR. Computing distributions for exact logistic regression. J Am Stat Assoc 1987; 82:1110-7.
16. Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97:1837-47.
17. Mittlbock M, Schemper M. Explained variation for logistic regression. Stat Med 1996; 15:1987-97.
18. Centers for Disease Control and Prevention. Cases of HIV infection and AIDS in the United States, 2004. Available at: http://www.cdc.gov/hiv/topics/ surveillance/resources/reports/2004report/default.htm. Accessed 15 March 2006.
19. McQuillan GM, Kruszon-Moran D, Kottiri BJ, et al. Prevalence of HIV in the US household population: the National Health and Nutrition Examination Surveys, 1988 to 2002. J Acquir Immune Defic Syndr 2006; 41:651-6.
20. The DAD Study Group. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med 2007; 356:1723-35.
21. Lange RA, Hillis LD. Cardiovascular complications of cocaine use. N Engl J Med 2001; 345:351-8.
22. Kolodgie FD, Virmani R, Cornhill JF, Herderick EE, Smialek J. Increase in atherosclerosis and adventitial mast cells in cocaine abusers: an alternative mechanism of cocaine-associated coronary vasospasm and thrombosis. J Am Coll Cardiol 1991; 17:1553-60.
23. Dresser FA, Malekzadeh S, Roberts WC. Quantitative analysis of amounts of coronary arterial narrowing in cocaine addicts. Am J Cardiol 1990; 65:303-8.
24. Kolodgie FD, Farb A, Virmani R. Pathobiological determinants of cocaine-associated cardiovascular syndromes. Hum Pathol 1995; 26:583-6.
25. Virmani R. Cocaine-associated cardiovascular disease: clinical and pathological aspects. NIDA Res Monogr 1991; 108:220-9.
26. Kolodgie FD, Virmani R, Cornhill JF, et al. Cocaine: an independent risk factor for aortic sudanophilia: a preliminary report. Atherosclerosis 1992; 97:53-62.
27. Lai S, Lai H, Meng Q, et al. Effect of cocaine use on coronary calcium among black adults in Baltimore, Maryland. Am J Cardiol 2002; 90:326-8.
28. Lai S, Lima JAC, Lai H, et al. HIV-1 infection, cocaine, and coronary calcification. Arch Intern Med 2005; 165:690-5.
29. Moore RD, Keruly JC, Lucas GM. Increasing incidence of cardiovascular disease in HIV-infected persons in care [abstract 130]. In: Program and abstracts of the 10th Conference on Retroviruses and Opportunistic Infections (Boston). 2003.
30. Saves M, Raffi F, Capeau J, et al.; Antiproteases Cohorte (APROCO) Study Group. Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy. Clin Infect Dis 2002; 34:1396-405.
31. Pannu HK, Jacobs JE, Lai S, Fishman EK. Coronary CT angiography with 64-MDCT: assessment of vessel visibility. AJR Am J Roentgenol 2006; 187:119-26.
32. Raff GL, Gallagher MJ, O'Neill WW, et al. Diagnostic accuracy of noninvasive coronary angiography using 64-slice spiral computed tomography. J Am Coll Cardiol 2005; 46:552-7.
33. Leber AW, Knez A, von Ziegler F, et al. Quantification of obstructive and nonobstructive coronary lesions by 64-slice computed tomography: a comparative study with quantitative coronary angiography and intravascular ultrasound. J Am Coll Cardiol 2005; 46:147-54.
34. Leschka S, Alkadhi H, Plass A, et al. Accuracy of MSCT coronary angiography with 64-slice technology: first experience. Eur Heart J 2005; 26:1482-7.
35. Mollet NR, Cademartiri F, van Mieghem CA, et al. High-resolution spiral computed tomography coronary angiography in patients referred for diagnostic conventional coronary angiography. Circulation 2005; 112:2318-23.